510(k) device
NightOwl
Ectosense NV · Ventilatory Effort Recorder (MNR, Class II) · First FDA decision Mar 6, 2020, newest Feb 24, 2022Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
11
Naming "NightOwl"
MAUDE reports
2
Brand "NightOwl", since 2015
PubMed studies
20
Mentioning "NightOwl"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NightOwl
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NightOwl510(k)
K220028 · Decided Feb 24, 2022 · 50 days after receipt
Device type: Ventilatory Effort Recorder (MNR) · Anesthesiology & Respiratory
- NightOwl510(k)
K213463 · Decided Dec 16, 2021 · 50 days after receipt
Device type: Ventilatory Effort Recorder (MNR) · Anesthesiology & Respiratory
- NightOwl510(k)
K191031 · Decided Mar 6, 2020 · 323 days after receipt
Device type: Ventilatory Effort Recorder (MNR) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NightOwl", any status and sponsor, newest update first.
Herlev and Gentofte HospitalAcademic, hospital or other
NCT04760002 · 126 participants · Start Jan 25, 2021 · Primary completion Jan 1, 2023
Device: NightOwl · For: Obstructive Sleep Apnea
Sites: Copenhagen, Denmark
Zealand University HospitalAcademic, hospital or other
NCT07778121 · 43 participants · Start Sep 26, 2025 · Primary completion Aug 31, 2026
Device: Home Sleep Apnea Test · For: Type 2 Diabetes; Obstructive Sleep Apnea (OSA)
Sites: Køge, Denmark
Herlev and Gentofte HospitalAcademic, hospital or other
NCT06188247 · 25 participants · Start Dec 1, 2023 · Primary completion Jul 1, 2024
Device: NightOwl home-monitoring · For: Atrial Fibrillation; Sleep Apnea
Sites: Gentofte Municipality, Denmark
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NightOwl", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 1 injury, 0 death
Whole product code MNR
122 reports: 87 malfunction, 31 injury, 0 death
Newest reports for this brand
- NIGHTOWLOther
MW6001630 · Received Aug 31, 2026 · Event dated Aug 24, 2026
Device type: Ventilatory Effort Recorder (MNR)
Device problem as coded: Nonstandard Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NIGHTOWL HOME SLEEP TESTInjury
MW5145706 · Received Sep 15, 2023 · Event dated Jun 26, 2023
Device type: Ventilatory Effort Recorder (MNR)
Patient problem as coded: Apnea; Tachycardia; Malaise
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NightOwl"[tiab]. The summary above synthesizes these.
- Protocol for detecting unrecognized sleep apnea in patients with atrial fibrillation by a home-monitoring device: the DAN-APNO study.
Jensen MH, Dalgaard F, Laub RR, et al. · BMC Cardiovasc Disord · 2022Research Support, Non-U.S. Gov't
- A comparison of the bioscreen method and microscopy for the determination of lag times of individual cells of listeria monocytogenes.
Wu Y, Griffiths MW, McKellar RC · Lett Appl Microbiol · 2000Comparative Study, Research Support, Non-U.S. Gov't
- Prevalence of sleep apnea in unselected patients with atrial fibrillation by a home-monitoring device: The DAN-APNO study.
Jensen MH, Dalgaard F, Rude Laub R, et al. · Int J Cardiol Heart Vasc · 2023
- Context-aware analysis enhances autoscoring accuracy of home sleep apnea testing.
Massie F, Vits S, Verbraecken J, et al. · J Clin Sleep Med · 2025Multicenter Study, Research Support, Non-U.S. Gov't
- An Evaluation of the NightOwl Home Sleep Apnea Testing System.
Massie F, Mendes de Almeida D, Dreesen P, et al. · J Clin Sleep Med · 2018
- Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells.
Alnajjar S, Nolte I, Schille JT, et al. · In Vivo · 2022
- Immediate Postoperative Changes After Expansion Pharyngoplasty and Hypoglossal Nerve Stimulation.
Yu PK, Wong V, Cook K, et al. · Laryngoscope · 2025
- Feasibility of a decentralised trial of sleep apnoea screening in patients with atrial fibrillation.
Hashiba M, Al-Alak A, Nielsen SK, et al. · Dan Med J · 2025Clinical Trial
- Comparison of Home Sleep Devices and Sleep Study Testing in Hypoglossal Nerve Stimulation Patients.
Huyett P, Yu PK, Kent D, et al. · Laryngoscope · 2025Comparative Study, Multicenter Study
- The evaluation of a novel single-lead biopotential device for home sleep testing.
Massie F, Vits S, Verbraecken J, et al. · Sleep · 2025Multicenter Study
- Validation of a single-use and reusable home sleep apnea test based on peripheral arterial tonometry compared to laboratory polysomnography for the diagnosis of obstructive sleep apnea.
Lyne CJ, Hamilton GS, Turton ARE, et al. · J Clin Sleep Med · 2023
- Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines.
Liu W, Sender S, Kong W, et al. · Cancer Cell Int · 2020
Other devices of this type
Also filed under product code MNR.
- Apnea Risk Evaluation System (Ares)Advanced Brain Monitoring, Inc. · 510(k) 2012
- MATRx plusZephyr Sleep Technologies · 510(k) 2020
- Sansa HsatHuxley Medical · 510(k) 2025
- Watch-PAT200UItamar Medical , Ltd. · 510(k) 2017
- Snap Model 7 Snoring and Apnea Recording and Analysis SystemSnap Laboratories, LLC · 510(k) 2008
- Onera Sleep Test System (Onera STS)Onera B.V. · 510(k) 2023
- Wesper LabWesper, Inc. · 510(k) 2023
- WatchPAT ONE (WP1)Itamar Medical , Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.